Brian Robinson Selected Research

Brian Robinson Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 01/2013
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
3	Carcinoma (Carcinomatosis) 12/2016 - 03/2013
2	Atrial Fibrillation 01/2018 - 10/2016
2	Hemophilia B (Haemophilia B) 01/2015 - 01/2015
2	Hemorrhage 01/2015 - 01/2015
2	Carcinoma in Situ 01/2014 - 03/2013
1	Wounds and Injuries (Trauma) 03/2022
1	Epilepsy (Aura) 03/2022
1	Burns 01/2022
1	Stroke (Strokes) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Hemophilia A (Haemophilia) 01/2016
1	Varicocele 02/2014
1	Carcinogenesis 01/2014
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Male Infertility (Male Sterility) 01/2014
1	Leigh Disease (Leigh's Disease) 03/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2013
1	Pharyngitis (Sore Throat) 12/2011
1	Craniocerebral Trauma (Head Injury) 09/2011
1	Infections 07/2011
1	Parkinson Disease (Parkinson's Disease) 10/2005

Drug/Important Bio-Agent (IBA)

4	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2014
2	AndrogensIBA 01/2021 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
2	factor IX Fc fusion proteinIBA 01/2015 - 01/2015
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2015 - 01/2015
1	Coal (Coals)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2021
1	HydrogelsIBA 01/2018
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	TensinsIBA 01/2017
1	Drug CombinationsIBA 01/2017
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2017
1	Biological ProductsIBA 12/2016
1	IntegrinsIBA 12/2016
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 12/2016
1	Warfarin (Coumadin)FDA LinkGeneric 10/2016
1	AnticoagulantsIBA 10/2016
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	ISA-2011BIBA 01/2016
1	enzalutamideIBA 01/2016
1	factor VIII-Fc fusion proteinIBA 01/2016
1	Aromatase (CYP19)IBA 01/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	LigandsIBA 01/2016
1	SteroidsIBA 01/2016
1	Cyclin A1IBA 01/2016
1	salicylhydroxamic acid (SHAM)IBA 02/2014
1	Ubiquitin-Specific ProteasesIBA 01/2014
1	Oxidoreductases (Dehydrogenase)IBA 01/2014
1	Testosterone (Sustanon)FDA Link 01/2014
1	CyclinsIBA 01/2014
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 03/2013
1	NAD (NADH)IBA 03/2013
1	EnzymesIBA 03/2013
1	DNA (Deoxyribonucleic Acid)IBA 03/2013
1	Surface Antigens (Surface Antigen)IBA 01/2013
1	AntibodiesIBA 01/2013
1	AntigensIBA 01/2013
1	J591 monoclonal antibodyIBA 01/2013
1	Virulence Factors (Pathogenicity Factors)IBA 12/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2011
1	beta-Lactamases (beta-Lactamase)IBA 07/2011
1	Phosphotransferases (Kinase)IBA 10/2005

Therapy/Procedure

3	Therapeutics 01/2021 - 03/2013
3	Prostatectomy (Retropubic Prostatectomy) 01/2020 - 01/2017
2	Castration 01/2019 - 01/2013
2	Drug Therapy (Chemotherapy) 12/2016 - 01/2013
1	Prostheses and Implants (Prosthesis) 03/2022
1	Self-Help Devices (Assistive Technology) 01/2020
1	Precision Medicine 01/2017
1	Ligation 02/2014
1	Transurethral Resection of Prostate (TURP) 01/2014
1	Transurethral Resection of Bladder 03/2013
1	Cystectomy 03/2013
1	Neoadjuvant Therapy 03/2013
1	Radioimmunotherapy 01/2013
1	Transjugular Intrahepatic Portasystemic Shunt 09/2011